Serum cholesterol levels in patients with panic disorders: A comparison with major depression and schizophrenia

Psychiatry and Clinical Neurosciences

Volumn 51, Issue 1, 1997, Pages 31-34

  Yamada, Kumiko ^a   Tsutsumi, Takashi ^a   Fujii, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

cardiovascular diseases; hypercholesterolemia; mortality; panic disorder; risk factor

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; HETEROCYCLIC COMPOUND; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT;

ADULT; APPETITE DISORDER; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; MENTAL DISEASE; MORTALITY; PANIC; RISK FACTOR; SCHIZOPHRENIA;

EID: 0031055924     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1997.tb02363.x     Document Type: Article

References (20)

1. Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder. Arch. Gen. Psychiatry 1982; 39: 701-703.
2. Coryell W, Noyes R, House D. Mortality among outpatients with anxiety disorders. Am. J. Psychiatry 1986; 150: 508-510.
3. Weissman MM, Markowitz JS, Oulette R, Greenwald S, Kahan JP. Panic disorder and cardiovascular/cerebrovascular problems: Results from a community survey. Am. J. Psychiatry 1990; 147: 1504-1508.
4. Coryell W; Obsessive-compulsive disorder and primary unipolar depression. J. Nerv. Ment. Dis. 1981; 169: 220-224.
5. Coryell W. Diagnostic-specific mortality, primary unipolar depression and Briquet's syndrome (Somatization disorder). Arch. Gen. Psychiatry 1981; 38: 939-942.
6. Bajawa WK, Asnis GM, Sanderson WC, Irfan A, van Praag HM. High cholesterol levels in patients with panic disorder. Am. J. Psychiatry 1992; 149: 376-378.
7. Iida M. Gender differences in risk of cardiovascular diseases. Cardioangiology 1993; 13: 700-703.
8. Yeragani VK, Pohl R, Balon R, Ramesh C, Gritz D, Sheerwood P. Risk factors for cardiovascular illness in panic disorder. Neuropsychobiology 1990; 23: 134-139.
9. Reifman A, Windle M. High cholesterol levels in patients with panic disorder (letter). Am. J. Psychiatry 1993; 150: 527.
10. Tancer ME, Stein MB, Moul DE, Uhde TW. Normal serum cholesterol in panic disorder. Biol. Psychiatry 1990; 27: 99-101.
11. Sims A. Neurosis and mortality: Investigating an association. J. Psychosom. Res. 1984; 28: 353-362.
12. Coryell W. Panic disorder and mortality. Psychiatr. Clin. North Am. 1988; 11: 433-440.
13. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras S. Cardiovascular and symptomstic reduction effects of alprazolam and imipramine in patients with panic disorder: Results of a double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 1990; 10: 112-118.
14. Feder R. High cholesterol levels in patients with panic disorder (letter). Am. J. Psychiatry 1993; 150: 527.
15. Klag MJ, Forde DE, Mead LA, He J, Whelton PK, Liang K, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N. Engl. J. Med. 1993; 328: 313-318.
16. Gurny SM, Vega GL. Causes of high blood cholesterol. Circulation 1990; 81: 412-427.
17. Coryell W. Mortality after thirty to forty: Panic disorder compared with other psychiatric illnesses. In: Grinspoon L (ed.), Psychiatry Update, the American Psychiatric Association Annual Review, Vol III. APA, Washington DC, 1987; 460-467.
18. Mabuchi H. Outline of the second report of the National Cholesterol Education Program (NECP) expert committee (ATP II) on the detection, assessment and treatment of adult hypercholersterolemia. JAMA 1993; 9: 133-147 (in Japanese).
19. Hayward C, Taylor CB, Roth WT, King R, Agras S. Plasma lipid levels in patients with panic disorder. Am. J. Psychiatry 1989; 146: 917-919.
20. Brown DW, Ketter TA, Crumlish J, Post RM. Carbamazepineinduced increases in total serum cholesterol: Clinical theoretical implications. J. Clin. Psychopharmacol 1992; 12: 431-437.